Artal Group S.A. Agios Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$33.87 - $55.93 $12.7 Million - $21 Million	-376,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $826,800 - $1.28 Million	-24,000 Reduced 6.0%	376,000 $20.1 Million
Q1 2020 May 14, 2020	SELL	$31.52 - $53.81 $6.3 Million - $10.8 Million	-200,000 Reduced 33.33%	400,000 $14.2 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $6.02 Million - $10.1 Million	200,000 Added 50.0%	600,000 $28.7 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $3.24 Million - $4.96 Million	-100,000 Reduced 20.0%	400,000 $13 Million
Q2 2019 Aug 09, 2019	BUY	$46.17 - $68.1 $4.62 Million - $6.81 Million	100,000 Added 25.0%	500,000 $24.9 Million
Q4 2018 Feb 11, 2019	BUY	$42.73 - $76.53 $4.27 Million - $7.65 Million	100,000 Added 33.33%	400,000 $18.4 Million
Q3 2018 Nov 09, 2018	SELL	$71.67 - $91.95 $3.58 Million - $4.6 Million	-50,000 Reduced 14.29%	300,000 $23.1 Million
Q2 2018 Aug 10, 2018	SELL	$73.22 - $99.55 $11 Million - $14.9 Million	-150,000 Reduced 30.0%	350,000 $29.5 Million
Q4 2017 Feb 09, 2018	BUY	$52.12 - $72.33 $2.61 Million - $3.62 Million	50,000 Added 11.11%	500,000 $28.6 Million
Q3 2017 Nov 08, 2017	BUY	$54.89 - $67.12 $24.7 Million - $30.2 Million	450,000	450,000 $30 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.